All Stories

  1. Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

    Article • PLoS Medicine, March 2021, PLOS

    Prof Sagnik Bhattacharyya

  2. Cannabidiol as a potential treatment for psychosis

    Article • Therapeutic Advances in Psychopharmacology, January 2019, SAGE Publications

    Prof Sagnik Bhattacharyya

  3. Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing.

    Article • Experimental and Clinical Psychopharmacology, August 2018, American Psychological Association (APA)

    Prof Sagnik Bhattacharyya, Dr Marco Colizzi

  4. Developmental sensitivity to cannabis use patterns and risk for major depressive disorder in mid-life: findings from 40 years of follow-up

    Article • Psychological Medicine, April 2018, Cambridge University Press

    Prof Sagnik Bhattacharyya

  5. Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders

    Article • Journal of Psychopharmacology, March 2018, SAGE Publications

    Prof Sagnik Bhattacharyya

  6. Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC

    Article • Psychological Medicine, March 2018, Cambridge University Press

    Prof Sagnik Bhattacharyya

  7. Does thinner right entorhinal cortex underlie genetic liability to cannabis use?

    Article • Psychological Medicine, February 2018, Cambridge University Press

    Prof Sagnik Bhattacharyya

  8. Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis

    Article • Psychiatry Research, September 2017, Elsevier

    Prof Sagnik Bhattacharyya

  9. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis

    Article • The Lancet Psychiatry, August 2017, Elsevier

    Prof Sagnik Bhattacharyya

  10. Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition

    Article • Current Addiction Reports, April 2017, Springer Science + Business Media

    Prof Sagnik Bhattacharyya, Dr Marco Colizzi

  11. The effects of cannabis use on salience attribution: a systematic review

    Article • Acta Neuropsychiatrica, November 2016, Cambridge University Press

    Prof Sagnik Bhattacharyya

  12. Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis

    Article • JAMA Psychiatry, November 2016, American Medical Association (AMA)

    Prof Sagnik Bhattacharyya

  13. Effect of experimental endocannabinoid modulation on brain function in individuals at high risk for psychosis

    Article • October 2016, Springer Science + Business Media

    Prof Sagnik Bhattacharyya

  14. Effects of cannabidiol treatment on cortisol response to social stress in subjects at high risk of developing psychosis

    Article • Psychoneuroendocrinology, September 2016, Elsevier

    Prof Sagnik Bhattacharyya

  15. REDUCED SUPRAMARGINAL GYRUS GRAY MATTER VOLUME ASSOCIATED WITH COGNITIVE IMPAIRMENT IN ALZHEIMER’S DISEASE: A 7-TESLA MRI STUDY

    Article • Alzheimer s & Dementia, July 2016, Elsevier

    Prof Sagnik Bhattacharyya

  16. Correlation still does not imply causation – Authors' reply

    Article • The Lancet Psychiatry, May 2016, Elsevier

    Prof Sagnik Bhattacharyya

  17. Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence

    Article • Neuroscience & Biobehavioral Reviews, May 2016, Elsevier

    Prof Sagnik Bhattacharyya, Dr Marco Colizzi

  18. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study

    Article • BMJ Open, January 2016, BMJ

    Prof Sagnik Bhattacharyya

  19. Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review

    Article • Journal of Psychopharmacology, October 2015, SAGE Publications

    Prof Sagnik Bhattacharyya

  20. Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids

    Article • Psychological Medicine, September 2015, Cambridge University Press

    Prof Sagnik Bhattacharyya

  21. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date

    Article • European Neuropsychopharmacology, August 2015, Elsevier

    Prof Sagnik Bhattacharyya

  22. Cannabis use and treatment resistance in first episode psychosis: a natural language processing study

    Article • The Lancet, February 2015, Elsevier

    Prof Sagnik Bhattacharyya

  23. A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders

    Article • Psychiatry Research, January 2015, Elsevier

    Prof Sagnik Bhattacharyya

  24. Road work on memory lane—Functional and structural alterations to the learning and memory circuit in adults born very preterm

    Article • NeuroImage, November 2014, Elsevier

    Prof Sagnik Bhattacharyya

  25. Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience

    Article • Neuropsychopharmacology, September 2014, Springer Science + Business Media

    Prof Sagnik Bhattacharyya

  26. Recreational Cannabis: The Risk of Schizophrenia

    Article • August 2014, Oxford University Press (OUP)

    Prof Sagnik Bhattacharyya

  27. Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC)

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, July 2014, Elsevier

    Prof Sagnik Bhattacharyya

  28. Acute and Non-acute Effects of Cannabis on Human Memory Function: A Critical Review of Neuroimaging Studies

    Article • Current Pharmaceutical Design, May 2014, Bentham Science Publishers

    Prof Sagnik Bhattacharyya

  29. Editorial (Thematic Issue: Neurobiological and Neurocognitive Basis of the Effects of Cannabinoids in Animals and Man: Therapeutic Potential of Cannabinoids in Psychiatry)

    Article • Current Pharmaceutical Design, May 2014, Bentham Science Publishers

    Prof Sagnik Bhattacharyya

  30. Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review

    Article • Current Pharmaceutical Design, May 2014, Bentham Science Publishers

    Prof Sagnik Bhattacharyya

  31. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control

    Article • Psychological Medicine, April 2014, Cambridge University Press

    Prof Sagnik Bhattacharyya

  32. Poster #T214 A SYSTEMATIC REVIEW OF FACTORS INFLUENCING ANTIPSYCHOTIC MEDICATION ADHERENCE IN SCHIZOPHRENIA

    Article • Schizophrenia Research, April 2014, Elsevier

    Prof Sagnik Bhattacharyya

  33. Poster #M125 THE EFFECTS OF CANNABIS ON RELAPSE IN PSYCHOSIS

    Article • Schizophrenia Research, April 2014, Elsevier

    Prof Sagnik Bhattacharyya

  34. Neural compensation in adulthood following very preterm birth demonstrated during a visual paired associates learning task

    Article • NeuroImage Clinical, January 2014, Elsevier

    Prof Sagnik Bhattacharyya

  35. Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort

    Article • Biological Psychiatry, July 2013, Elsevier

    Prof Sagnik Bhattacharyya

  36. Dhat Syndrome: A Systematic Review

    Article • Psychosomatics, May 2013, Elsevier

    Prof Sagnik Bhattacharyya

  37. Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings

    Article • PLoS ONE, February 2013, PLOS

    Prof Sagnik Bhattacharyya

  38. Modulation of brain structure by catechol‐O‐methyltransferase Val158Met polymorphism in chronic cannabis users

    Article • Addiction Biology, January 2013, Wiley

    Prof Sagnik Bhattacharyya

  39. The effect of cannabis use on memory function: an update

    Article • Substance Abuse and Rehabilitation, January 2013, Taylor & Francis

    Prof Sagnik Bhattacharyya

  40. Effect of BDNF val66met polymorphism on declarative memory and its neural substrate: A meta-analysis

    Article • Neuroscience & Biobehavioral Reviews, October 2012, Elsevier

    Prof Sagnik Bhattacharyya

  41. Neural Mechanisms for the Cannabinoid Modulation of Cognition and Affect in Man: A Critical Review of Neuroimaging Studies

    Article • Current Pharmaceutical Design, September 2012, Bentham Science Publishers

    Prof Sagnik Bhattacharyya

  42. A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation

    Article • Current Pharmaceutical Design, September 2012, Bentham Science Publishers

    Prof Sagnik Bhattacharyya

  43. THE EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL AND CANNABIDIOL ON BRAIN FUNCTION IN MAN

    Article • Schizophrenia Research, April 2012, Elsevier

    Prof Sagnik Bhattacharyya

  44. 15:00 BIOLOGICAL BASIS OF SENSITIVITY TO THE EFFECTS OF CANNABIS ON PSYCHOSIS: AKT1 AND DAT1 GENOTYPE MODULATES THE EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL ON MIDBRAIN AND STRIATAL FUNCTION

    Article • Schizophrenia Research, April 2012, Elsevier

    Prof Sagnik Bhattacharyya

  45. THE LINK BETWEEN CANNABIS AND SCHIZOPHRENIA: DOPAMINERGIC OR CANNABINOID SYSTEM?

    Article • Schizophrenia Research, April 2012, Elsevier

    Prof Sagnik Bhattacharyya

  46. Substance use and regional gray matter volume in individuals at high risk of psychosis

    Article • European Neuropsychopharmacology, February 2012, Elsevier

    Prof Sagnik Bhattacharyya

  47. Neuroimaging Evidence for Cannabinoid Modulation of Cognition and Affect in Man

    Article • Frontiers in Behavioral Neuroscience, January 2012, Frontiers

    Prof Sagnik Bhattacharyya

  48. Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

    Article • Archives of General Psychiatry, January 2012, American Medical Association (AMA)

    Prof Sagnik Bhattacharyya

  49. The neural basis for the acute effects of cannabis on learning and psychosis

    Article • October 2011, Cambridge University Press

    Prof Sagnik Bhattacharyya

  50. Altered medial temporal activation in subjects with prodromal signs of psychosis related to glutamate levels

    Article • International Clinical Psychopharmacology, September 2011, Wolters Kluwer Health

    Prof Sagnik Bhattacharyya

  51. Altered Medial Temporal Activation Related to Local Glutamate Levels in Subjects with Prodromal Signs of Psychosis

    Article • Biological Psychiatry, January 2011, Elsevier

    Prof Sagnik Bhattacharyya

  52. Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms

    Article • Neuropsychopharmacology, December 2010, Springer Science + Business Media

    Prof Sagnik Bhattacharyya

  53. WHY DOES CANNABIS EFFECT PEOPLE DIFFERENTLY? COMPARING THOSE WITH TEMPORARY PSYCHOTIC SYMPTOMS VS. THOSE WITH NO PSYCHOTIC SYMPTOMS FOLLOWING THE ORAL ADMINISTRATION OF Δ-9-TETRAHYDROCANNABINOL – A FUNCTIONAL MRI STUDY

    Article • Schizophrenia Research, April 2010, Elsevier

    Prof Sagnik Bhattacharyya

  54. ALTERED MEDIAL TEMPORAL ACTIVATION RELATED TO LOCAL GLUTAMATE IN SUBJECTS WITH PRODROMAL SIGNS OF PSYCHOSIS

    Article • Schizophrenia Research, April 2010, Elsevier

    Prof Sagnik Bhattacharyya

  55. EFFECT OF BDNF MET66VAL POLYMORPHISM ON HIPPOCAMPAL STRUCTURE AND FUNCTION: A META-ANALYSIS

    Article • Schizophrenia Research, April 2010, Elsevier

    Prof Sagnik Bhattacharyya

  56. Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

    Article • Neuropsychopharmacology, November 2009, Springer Science + Business Media

    Prof Sagnik Bhattacharyya

  57. Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol

    Article • The International Journal of Neuropsychopharmacology, September 2009, Oxford University Press (OUP)

    Prof Sagnik Bhattacharyya

  58. Cannabis and anxiety: a critical review of the evidence

    Article • Human Psychopharmacology Clinical and Experimental, August 2009, Wiley

    Prof Sagnik Bhattacharyya

  59. Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder

    Article • Neuropsychopharmacology, August 2009, Springer Science + Business Media

    Prof Sagnik Bhattacharyya

  60. Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol

    Article • Archives of General Psychiatry, April 2009, American Medical Association (AMA)

    Prof Sagnik Bhattacharyya

  61. Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

    Article • Archives of General Psychiatry, January 2009, American Medical Association (AMA)

    Prof Sagnik Bhattacharyya

  62. Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition

    Article • Biological Psychiatry, December 2008, Elsevier

    Prof Sagnik Bhattacharyya

  63. DELTA-9-TETRAHYDROCANNABINOL MODULATES MEDIAL TEMP AND STRIATAL FUNCTION IN HUMANS: A NEURAL BASIS FOR THE EFFECTS OF CANNABIS ON MEMORY AND PSYCHOSIS

    Article • Schizophrenia Research, June 2008, Elsevier

    Prof Sagnik Bhattacharyya

  64. Glutamatergic Dysfunction-Newer Targets for Anti-Obsessional Drugs

    Article • Recent Patents on CNS Drug Discovery, January 2007, Bentham Science Publishers

    Prof Sagnik Bhattacharyya

  65. Anti-depressive Therapies After Heart Transplantation

    Article • The Journal of Heart and Lung Transplantation, July 2006, Elsevier

    Prof Sagnik Bhattacharyya

  66. A family genetic study of clinical subtypes of obsessive-compulsive disorder

    Article • Psychiatric Genetics, September 2005, Wolters Kluwer Health

    Prof Sagnik Bhattacharyya

  67. Glutamatergic Dysfunction in OCD

    Article • Neuropsychopharmacology, April 2005, Springer Science + Business Media

    Prof Sagnik Bhattacharyya

  68. Depressive and Anxiety Disorder Comorbidity in Obsessive Compulsive Disorder

    Article • Psychopathology, January 2005, Karger Publishers

    Prof Sagnik Bhattacharyya

  69. Late onset OCD

    Article • Australian & New Zealand Journal of Psychiatry, June 2004, SAGE Publications

    Prof Sagnik Bhattacharyya

  70. Early-Onset Obsessive—Compulsive Disorder

    Article • The Canadian Journal of Psychiatry, June 2003, SAGE Publications

    Prof Sagnik Bhattacharyya

  71. Metamorphosis of Delusion of Pregnancy

    Article • The Canadian Journal of Psychiatry, August 2001, SAGE Publications

    Prof Sagnik Bhattacharyya